Profile data is unavailable for this security.
About the company
Waters Corporation offers analytical instruments and software across chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Its segments include Waters and TA. The Waters segment is primarily in the business of designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instrument systems, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA segment is primarily in the business of designing, manufacturing, selling and servicing thermal analysis, rheometry and calorimetry instruments.
- Revenue in USD (TTM)2.88bn
- Net income in USD595.69m
- Incorporated1991
- Employees7.90k
- LocationWaters Corp34 MAPLE STMILFORD 01757-3604United StatesUSA
- Phone+1 (508) 478-2000
- Fax+1 (508) 872-1990
- Websitehttps://www.waters.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revvity Inc | 2.71bn | 197.34m | 15.29bn | 11.50k | 77.61 | 1.94 | 24.41 | 5.65 | 1.60 | 1.37 | 21.90 | 63.80 | 0.1959 | 2.89 | 4.42 | 235,499.60 | 1.43 | 4.76 | 1.59 | 5.39 | 55.26 | 57.19 | 7.29 | 15.34 | 1.98 | 6.89 | 0.3299 | 6.52 | -16.95 | -0.1982 | -64.99 | -5.28 | -2.69 | 0.00 |
Insulet Corp | 1.87bn | 395.30m | 16.12bn | 3.00k | 42.48 | 16.15 | 34.24 | 8.61 | 5.41 | 5.41 | 24.53 | 14.24 | 0.711 | 1.38 | 6.25 | 624,233.30 | 15.01 | 2.71 | 18.15 | 3.14 | 69.00 | 65.81 | 21.11 | 4.28 | 2.71 | 87.97 | 0.5833 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
Avantor Inc | 6.83bn | 360.20m | 17.21bn | 14.50k | 47.80 | 3.16 | 22.61 | 2.52 | 0.5295 | 0.5295 | 10.03 | 8.00 | 0.530 | 5.37 | 5.82 | 470,731.00 | 2.80 | 2.97 | 3.17 | 3.35 | 33.71 | 33.44 | 5.28 | 5.06 | 1.05 | 3.07 | 0.4848 | 0.00 | -7.26 | 3.51 | -51.52 | -- | 31.17 | -- |
Align Technology, Inc. | 3.94bn | 447.03m | 18.03bn | 21.61k | 40.93 | 4.80 | 30.72 | 4.57 | 5.90 | 5.90 | 52.03 | 50.31 | 0.641 | 4.16 | 4.09 | 182,455.40 | 7.27 | 16.34 | 10.96 | 24.14 | 69.82 | 71.72 | 11.34 | 23.16 | 1.06 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
Baxter International Inc | 15.00bn | -157.00m | 18.53bn | 60.00k | -- | 2.42 | 16.69 | 1.24 | -0.3066 | 4.87 | 29.48 | 14.98 | 0.5534 | 3.24 | 5.73 | 249,950.00 | -0.5462 | 0.1942 | -0.7019 | 0.2333 | 36.48 | 38.20 | -0.9869 | 0.3674 | 0.9147 | 4.25 | 0.626 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
Hologic Inc | 3.99bn | 701.50m | 18.64bn | 6.99k | 27.38 | 3.76 | 18.43 | 4.67 | 2.93 | 2.93 | 16.59 | 21.33 | 0.4375 | 2.64 | 6.06 | 570,472.10 | 7.70 | 11.40 | 8.64 | 13.38 | 55.41 | 60.29 | 17.59 | 20.95 | 3.32 | 709.77 | 0.3408 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
Waters Corp | 2.88bn | 595.69m | 20.93bn | 7.90k | 35.12 | 14.82 | 26.57 | 7.27 | 10.04 | 10.04 | 48.46 | 23.79 | 0.6394 | 2.19 | 4.41 | 364,118.20 | 13.24 | 19.77 | 16.04 | 25.29 | 59.68 | 58.45 | 20.71 | 23.38 | 1.42 | 8.74 | 0.5869 | 0.00 | -0.5229 | 4.09 | -9.26 | 1.53 | 4.72 | -- |
Cooper Companies Inc | 3.80bn | 359.30m | 21.09bn | 15.00k | 58.98 | 2.66 | 28.66 | 5.55 | 1.80 | 1.80 | 19.02 | 39.80 | 0.3196 | 1.70 | 5.56 | 253,606.70 | 3.02 | 10.06 | 3.29 | 11.34 | 66.36 | 65.54 | 9.45 | 29.00 | 1.18 | 5.46 | 0.2493 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
Zimmer Biomet Holdings Inc | 7.52bn | 997.10m | 21.32bn | 18.00k | 21.82 | 1.68 | 10.86 | 2.83 | 4.80 | 4.80 | 36.22 | 62.18 | 0.3515 | 0.9141 | 5.40 | 418,050.00 | 4.66 | 2.21 | 5.40 | 2.52 | 71.78 | 71.25 | 13.27 | 7.28 | 0.629 | 7.54 | 0.314 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
West Pharmaceutical Services Inc. | 2.88bn | 524.90m | 21.51bn | 10.60k | 42.13 | 8.35 | 32.83 | 7.48 | 7.04 | 7.04 | 38.62 | 35.49 | 0.8037 | 4.26 | 5.68 | 271,405.70 | 14.22 | 15.61 | 16.93 | 18.65 | 35.69 | 38.06 | 17.70 | 18.47 | 1.68 | -- | 0.0751 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
Illumina Inc | 4.43bn | -3.04bn | 22.53bn | 10.59k | -- | 15.66 | -- | 5.09 | -19.18 | -19.18 | 27.94 | 9.03 | 0.4961 | 2.86 | 6.26 | 418,224.80 | -34.09 | -6.20 | -45.61 | -7.28 | 62.00 | 66.39 | -68.71 | -15.48 | 0.8596 | 14.07 | 0.6087 | -- | -1.75 | 6.21 | 73.64 | -- | -7.91 | -- |
Steris PLC | 5.13bn | 567.70m | 22.78bn | 18.18k | 40.38 | 3.59 | 20.53 | 4.44 | 5.72 | 4.03 | 51.73 | 64.32 | 0.4914 | 3.98 | 5.77 | 282,395.10 | 5.45 | 5.19 | 5.95 | 5.68 | 43.19 | 43.64 | 11.09 | 10.97 | 1.49 | 7.03 | 0.2666 | 36.56 | 13.28 | 13.06 | -1.07 | 12.67 | 13.69 | 8.83 |
DexCom Inc | 3.93bn | 666.90m | 27.29bn | 9.60k | 42.76 | 11.21 | 31.29 | 6.94 | 1.59 | 1.59 | 9.38 | 6.08 | 0.5778 | 2.92 | 4.64 | 409,875.00 | 9.79 | 8.30 | 13.57 | 10.50 | 63.16 | 65.90 | 16.95 | 14.14 | 2.48 | -- | 0.5063 | 0.00 | 24.49 | 28.56 | 58.70 | -- | 28.66 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Mar 2024 | 6.62m | 11.16% |
Fundsmith LLPas of 31 Mar 2024 | 4.90m | 8.27% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 3.80m | 6.41% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 2.54m | 4.28% |
Massachusetts Financial Services Co.as of 30 Jun 2024 | 2.42m | 4.08% |
AllianceBernstein LPas of 31 Mar 2024 | 2.29m | 3.85% |
Walter Scott & Partners Ltd.as of 30 Jun 2024 | 1.62m | 2.73% |
Generation Investment Management LLPas of 31 Mar 2024 | 1.53m | 2.58% |
Geode Capital Management LLCas of 30 Jun 2024 | 1.40m | 2.36% |
GuardCap Asset Management Ltd.as of 31 Mar 2024 | 1.11m | 1.87% |